.png){kind=icon}
.png){kind=icon}
Return
Statins in chronic liver disease and its complications: An umbrella review and meta-analysis of systematic reviews
.png){kind=icon}
OA
AI
F
F
V
M
A
M
L
D
L
A
DOI：10.1016/j.dld.2026.05.010.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Statins have been proposed as hepatoprotective agents in chronic liver disease (CLD); however, evidence from existing systematic reviews—including observational studies and clinical trials—is inconsistent and affected by substantial overlap. We conducted an umbrella review to synthesize the available evidence on the associations between statin use and hepatological outcomes in CLD patients, while addressing study overlap.
Keywords:
Hepatocellular carcinoma
Hepatic Decompensation
Meta-analysis
Mortality
Statins
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.8
Papers:
1.2W
Citations:
8.7K
Organization
Cited Papers